GSK was one of two drugmakers to issue refunds to 340B covered entities, according to notices posted on a government regulatory site.
GSK, Vertex Offer Refunds to 340B Providers
Views
Drugmakers GlaxoSmithKline and Vertex Pharmaceuticals will offer refunds to 340B providers related to the purchases of several of their high-earning [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.